English
This article is from Disease Models & Mechanisms , volume 5 . Abstract Individuals with metabolic syndrome are at high risk of developing chronic kidney disease (CKD) through unclear pathogenic mechanisms. Obesity and diabetes are known to induce glucolipotoxic effects in metabolically relevant organs. However, the pathogenic role of glucolipotoxicity in the aetiology of diabetic nephropathy is debated. We generated a murine model, the POKO mouse, obtained by crossing the peroxisome proliferator-activated receptor gamma 2 (PPARγ2) knockout (KO) mouse into a genetically obese ob/ob background. We have previously shown that the POKO mice showed: hyperphagia, insulin resistance, hyperglycaemia and dyslipidaemia as early as 4 weeks of age, and developed a complete loss of normal β-cell function by 16 weeks of age. Metabolic phenotyping of the POKO model has led to investigation of the structural and functional changes in the kidney and changes in blood pressure in these mice. Here we demonstrate that the POKO mouse is a model of renal disease that is accelerated by high levels of glucose and lipid accumulation. Similar to ob/ob mice, at 4 weeks of age these animals exhibited an increas
Sign in with your free account to read, download EPUBs or listen.
Ebook · Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. · Martinez-Garcia, Cristina, Izquierdo, Adriana, Velagapudi, Vidya, Vivas, Yurena, Velasco, Ismael, Campbell, Mark, Burling, Keith, Cava, Fernando · Internet Archive